Mariana R. Pereira

Porto, 4200319, Portugal

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications

Repurposing Antiretroviral Drugs for Urological Cancers: Differential Effects of Protease Inhibitors and NNRTIs on Prostate and Bladder Cancer Cells.

Repurposing Antiretroviral Drugs for Urological Cancers: Differential Effects of Protease Inhibitors and NNRTIs on Prostate and Bladder Cancer Cells.

Journal: Cells
Published: April 25, 2026

Gene Expression-Guided Drug Repurposing in Oncology: Insights from Antiretroviral Agents in Prostate and Bladder Cancer.

Gene Expression-Guided Drug Repurposing in Oncology: Insights from Antiretroviral Agents in Prostate and Bladder Cancer.

Journal: Genes
Published: December 31, 2025

Exploring Potential for Repurposing Antiretroviral Drugs Etravirine and Efavirenz in Prostate and Bladder Cancer.

Exploring Potential for Repurposing Antiretroviral Drugs Etravirine and Efavirenz in Prostate and Bladder Cancer.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 24, 2025

Cholesterol Functionalized Nanoparticles Are Effective against Helicobacter pylori, the Gastric Bug: A Proof-of-Concept Study.

Cholesterol Functionalized Nanoparticles Are Effective against Helicobacter pylori, the Gastric Bug: A Proof-of-Concept Study.

Journal: Advanced healthcare materials
Published: October 18, 2024

Ritonavir's Evolving Role: A Journey from Antiretroviral Therapy to Broader Medical Applications.

Ritonavir's Evolving Role: A Journey from Antiretroviral Therapy to Broader Medical Applications.

Journal: Current oncology (Toronto, Ont.)
Published: August 31, 2024

Embryological, clinical, and newborn outcomes from 583 treatment cycles with fresh and frozen testicular spermatozoa.

Embryological, clinical, and newborn outcomes from 583 treatment cycles with fresh and frozen testicular spermatozoa.

Journal: Andrology
Published: May 24, 2024

Exploring Darunavir, Rilpivirine and Etravirine as Potential Therapies for Bladder Cancer: Efficacy and Synergistic Effects.

Exploring Darunavir, Rilpivirine and Etravirine as Potential Therapies for Bladder Cancer: Efficacy and Synergistic Effects.

Journal: Biomedicines
Published: February 10, 2024

A Comprehensive Look at In Vitro Angiogenesis Image Analysis Software.

A Comprehensive Look at In Vitro Angiogenesis Image Analysis Software.

Journal: International journal of molecular sciences
Published: November 16, 2023

Advancing Precision Medicine: A Review of Innovative In Silico Approaches for Drug Development, Clinical Pharmacology and Personalized Healthcare.

Advancing Precision Medicine: A Review of Innovative In Silico Approaches for Drug Development, Clinical Pharmacology and Personalized Healthcare.

Journal: Pharmaceutics
Published: November 01, 2023

Systemic Inflammatory Disorders, Immunosuppressive Treatment and Increase Risk of Head and Neck Cancers-A Narrative Review of Potential Physiopathological and Biological Mechanisms.

Systemic Inflammatory Disorders, Immunosuppressive Treatment and Increase Risk of Head and Neck Cancers-A Narrative Review of Potential Physiopathological and Biological Mechanisms.

Journal: Cells
Published: July 22, 2023

Repurposing Benztropine, Natamycin, and Nitazoxanide Using Drug Combination and Characterization of Gastric Cancer Cell Lines.

Repurposing Benztropine, Natamycin, and Nitazoxanide Using Drug Combination and Characterization of Gastric Cancer Cell Lines.

Journal: Biomedicines
Published: February 10, 2023

Atorvastatin and Nitrofurantoin Repurposed in the Context of Breast Cancer and Neuroblastoma Cells.

Atorvastatin and Nitrofurantoin Repurposed in the Context of Breast Cancer and Neuroblastoma Cells.

Journal: Biomedicines
Published: February 08, 2023
Showing 1-12 of 35

Last Updated: 09/26/2026